COVID-19 Reactogenicity

NCT07051031 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Nuvaxovid (NVX-CoV2705)
DRUG: mNEXSPIKE mRNA-1283

Sponsor

Marcel Curlin